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Open access under CHere we present a multipotent neuronal progenitor cell line for toxicity testing as an alternative to pri-
mary cultures of mixed cell types from brain tissue. The v-myc immortalised C17.2 cell line, originally
cloned from mouse cerebellar neural stem cells, were maintained as monolayer in cell culture dishes
in DMEM supplemented with fetal calf serum, horse serum and antibiotics. Different media and exposure
scenarios were used to induce differentiation. The optimal condition which generated mixed cultures of
neurons and astrocytes included serum-free DMEM:F12 medium with N2 supplements, brain-derived
neurotrophic factor and nerve growth factor. The medium was changed every 3rd or 4th day to fresh
N2 medium with supplements. After 7 days, the culture contained two different morphological cell types,
assumed to be neurons and glia cells. The presence of astrocytes and neurons in the culture was con-
ﬁrmed by RT-PCR andWestern blot analyses, indicating increased mRNA and protein levels of the speciﬁc
biomarkers glial ﬁbrillary acidic protein (GFAP) and bIII-tubulin, respectively. Concomitantly, the expres-
sion of the neural progenitor cell marker nestin was down-regulated.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Neurotoxicity studies using alternative methods to animal
models are usually performed on established cell lines, primary
cultures or non-mammalian cell models (Aschner et al., 2011;
Bal-Price et al., 2008; Costa et al., 2011; Llorens et al., 2012; Peter-
son et al., 2008; Smith, 2009). However, primary brain tissue cul-
tures of mixed cell types should be the most physiological
in vitro cell model for estimation of neurotoxicity. Indeed, glia cells
have been shown to modulate sensitivity of neurons to chemical
insult (Eskes et al., 1999; Morken et al., 2005; Zurich et al.,
2004). The complexity of the brain structure and cell–cell commu-
nication is difﬁcult to mimic with the cloned cell line approach
(Forsby et al., 2009). Nevertheless, for animal welfare reasons
and for simplicity of toxicity test strategies, the usage of primary
cultures should be minimised. Still, complex systems must be
available for toxicity tests. Here we present a multipotent neural
progenitor cell line, C17.2, as an alternative to the primary brain
tissue cultures. The C17.2 cell line originates from neural stem cellsc factor; DMEM, Dulbecco’s
GAPDH, glyceraldehyde 3-
ic protein; HS, horse serum;
RT-PCR, reverse transcriptase
hate.
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C BY-NC-ND license. of the external germinal layer of mouse cerebellum, which were
immortalised by v-myc transfection (Snyder et al., 1992).
All-trans retinoic acid (RA) is known to induce differentiation in
embryonic stem cells (Kim et al., 2009) and in several cell lines
(Pahlman et al., 1984, 1990). Previous results show that RA seems
to promote astrocyte differentiation rather than neuronal develop-
ment in C17.2 cells (Asano et al., 2009; Bajinskis et al., 2011). In
order to obtain mixed cultures with more equal distribution of
neurons and astrocytes, three types of cell culture media for the
C17.2 cells were tested: (1) Dulbecco’s modiﬁed essential medium
(DMEM) with horse serum and fetal calf serum (HS and FCS,
respectively), (2) FCS-deprived DMEM, supplemented with nerve
growth factor (NGF) and brain-derived neurotrophic factor (BDNF)
and (3) serum-free DMEM:F12 medium with N2 supplements, NGF
and BDNF. The media were either not changed during the differen-
tiation period (autocrine-conditioned medium) or changed every
3rd to 4th day to fresh medium. The autocrine-conditioned media
were either supplemented with extra NGF and BDNF every 3rd to
4th day or left without extra additions. Concomitantly with mor-
phological studies, expression of the cell-speciﬁc biomarkers nes-
tin (a type-IV intermediate ﬁlament identifying neural progenitor
cells) (Frederiksen and McKay, 1988; Lendahl and McKay, 1990),
bIII-tubulin (part of the microtubular complex identifying neurons)
(Roskams et al., 1998) and glial ﬁbrillary acidic protein (GFAP, a
type-III intermediate ﬁlament identifying astrocytes) (Eng et al.,
1971) were used to validate the different cell types in the cultures.
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2.1. Cell lines and culture medium
The C17.2 cells are mouse-derived multipotent neural stem
cells isolated from cerebellum, which were immortalised by avian
myelocytomatosis viral-related oncogene (v-myc) transfection
(Snyder et al., 1992). The cells were a generous gift from Professor
Sandra Ceccatelli (Karolinska Institute, Stockholm, Sweden), with
permission of Prof. Evan Snyder (Harvard Medical School, Boston,
USA).
The C17.2 cells were grown in cell culture dishes (Corning Inc.,
Corning NY) in DMEM supplemented with 5% HS, 10% FCS, 2 mM
L-glutamine, 100 U penicillin/ml and 100 lg streptomycin/ml (all
from Life Technologies, Gibco, Invitrogen), referred to as com-
plete DMEM, in a humidiﬁed atmosphere of 5% CO2 in air at
37 C. The cells were detached every 3rd to 4th day using 0.05/
0.02% trypsin/EDTA and reseeded in 55 cm2 cell culture dishes
at a density of 1.5  105 cells/dish in 10 ml complete DMEM.
For differentiation experiments, cells were seeded in complete
DMEM which was changed to differentiation medium one day
post seeding. Three different differentiation medium composi-
tions were used; (1) complete DMEM, (2) complete DMEM with-
out FCS but supplemented with NGF and BDNF [10 ng/ml of each
neurotrophic factor], and (3) DMEM:F12 medium with N2 sup-
plements (Bottenstein and Sato, 1979) together with NGF and
BDNF (RnD systems Inc.). Along with the three different media,
three different exposure conditions were studied; conditioned
medium (no change of differentiation medium for 7 days), ex-
change of the differentiation medium every 3rd day and condi-
tioned differentiation medium with addition of NGF and BDNF
to the media every 3rd day. The differentiation conditions are
summarised in Table 1.2.2. Morphology study
To morphologically characterise the differentiation process,
2.15  103 cells were seeded in a 8 cm2 cell culture plate in com-
plete DMEM one day prior medium change. The cells undergoing
differentiation were treated for 7 days. Native neural stem cells
kept in complete DMEM for 3 days were used as control cells. In
addition to the nine exposure scenarios described above and in
Table 1 for 7 days, the morphological differentiation process was
followed in more detail at day 3, 7 and 10 by culturing the cells
in DMEM:F12 medium with N2 supplements, NGF and BDNF
[10 ng/ml] with a change of the medium every 3rd day.Table 1
Cell culture conditions for differentiation of C17.2 All media were supplemented with
L-glutamine, penicillin and streptomycin, see Methods.
Complete DMEM
with 5% HS and 10%
FCS
DMEM with 5% HS, NGF
and BDNF [10 ng/ml]a
DMEM:F12 medium with
N2 supplements, NGF and
BDNF [10 ng/ml]a
(1) Control cells
cultured for
3 days
(4) Conditioned medium,
no medium change for
7 days
(7) Conditioned medium,
no medium change for
7 days
(2) Conditioned
medium, no
medium change
for 8 days
(5), Cells in
differentiation medium
for 7 days, medium
change after 3 days
(8) Cells in differentiation
medium for 7 days,
medium change after
3 days
(3) Cells in culture
for 8 days,
medium change
after 4 days
(6) Conditioned medium,
extra addition of NGF and
BDNF after 3 days
(9) Conditioned medium,
extra addition of NGF and
BDNF after 3 days
a Cells were plated in complete DMEM the day before the change to differenti-
ation medium.2.3. RT-PCR
For analysis with reverse transcriptase (RT)-polymerase chain
reaction (PCR), 1.9  104 cells were seeded in an 8 cm2 cell culture
plate in complete DMEM one day prior medium was changed to
the differentiation media. Cells were lysed and mRNA was isolated
using the Qiagen RNeasy kit (Fermenta) after 7 days of exposure for
the differentiation conditions (Table 1). Native cells kept in com-
plete DMEM medium for three days were used as the neural stem
cell control. Two lg of RNA was reversed transcribed to yield cDNA
by the use of speciﬁc primers. The following primer sequences
were used; nestin 5‘-GGAGGGCAGAGAAGACAGTG-3‘ and 5‘-TGAC
ATCCTGGACCTTGACA-3‘, bIII-tubulin 5‘-GAATGACCTGGTGTCCG
AGT-3‘ and 5‘-CAGAGCCAAGTGGACTCACA-3‘ and GFAP 5‘-CAC
GAACGAGTCCCTAGAGC-3‘ and 5‘-TCACATCACCACGTCCTTGT-3‘
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
used as an internal reference; 5‘-GGCATTGCTCTCAATGACAA-3‘
and 5‘-TGTGAGGGAGATGCTCAGTG-3‘. The mRNA levels of nestin,
bIII-tubulin and GFAP were analysed after 22–26 PCR cycles. The
PCR products were analysed on 1.5% agarose gels and visualised
with ethidium bromide and UV radiation. The intensity of the
bands was quantiﬁed with the Image Gauge 3.46 program (Fujiﬁlm
Co. Ltd.).
2.4. Protein levels and western blot
Based on the results from the morphological evaluation and
mRNA expression, the protein expression levels after differentia-
tion were studied. 1.9  104 cells were seeded in a 55 cm2 cell cul-
ture plate in complete DMEM one day prior differentiation.
Differentiation proceeded in DMEM:F12 with N2 supplements,
NGF and BDNF [10 ng/ml of each neurotrophic factor] (treatment
8 in Table 1) followed by Western blot analysis. The cells were
lysed in a hypotonic buffer containing NP-40. Twenty lg of total
protein (determined with the DC Protein Assay, BioRad) were sep-
arated in 10% SDS- poly-acrylamide gels. The proteins were subse-
quently transferred to nitrocellulose membranes and hybridised
with primary antibodies diluted accordingly: bIII-tubulin
(ab18207) 1:5000, nestin (ab6142) 1:200 and GFAP (ab7260)
1:1000 (all from Abcam) and b-actin (sc-1616) 1:5000 (Santa
Cruz). Horse radish peroxidase-conjugated anti-rabbit IgG
(NA934 V) 1:3000 and anti-mouse IgG (NA931 V) 1:3000 (Amer-
sham) and anti-goat IgG (sc-2020) 1:3000 (Santa Cruz) were used
as secondary antibodies. Densitometric analysis of visual blots was
performed using Image Gauge 3.46 program (Fujiﬁlm Co. Ltd.).3. Statistical analyses
The data were analysed using one-way ANOVA followed by
Tukey’s Multiple Comparison Test (Fig. 2a–c) or by Student’s t-test
(Fig. 3) (GraphPad Prism 5.0).4. Results
4.1. Morphology of differentiated C17.2 cells
Cells grown in complete DMEM for 3 days (treatment 1 in Ta-
ble 1) remained their native, neural stem cell state. Only one mor-
phological phenotype with no visual outgrowth of neurites was
observed in the cultures (Fig. 1a). For cells grown in conditioned
complete DMEM for 8 days (treatment 2 in Table 1) or with med-
ium change after day 4 (treatment 3 in Table 1) no morphological
signs of neuronal differentiation were observed (not shown). Cells
cultured for 7 days in complete DMEM without FCS but with neu-
rotrophic factors added (treatment 4–6 in Table 1) displayed
Fig. 1. Morphology of neural progenitor C17.2 cells and differentiated C17.2 cells. Cells were grown in complete DMEM for 3 days (a) or in DMEM:F12 medium with N2
supplements, NGF and BDNF for (b) 3 days, (c) 7 days and (d) 10 days. Cultures presumably containing neurons and astrocytes cells were apparent after 7 and 10 days in
culture with differentiation medium (c and d). Scale bar 50 lm.
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DMEM:F12 medium with N2 supplements and neurotrophic fac-
tors (treatment 7–9 in Table 1). The cultures displayed two distinct
layers of cells with different morphology (Fig. 1c). To further eluci-
date the progress of morphological differentiation, cells were also
examined after 3, 7 and 10 days in DMEM:F12 medium with N2
supplements, NGF and BDNF with a medium change every 4th
day. After 3 days in this medium, some cells had formed neurites
and changed their morphology to a dense cell body (Fig. 1b), as
compared to most of the cells in the culture, but also as compared
to the undifferentiated progenitor control cells (Fig. 1a). After
7 days in DMEM:F12 medium with N2 supplements, NGF and
BDNF, the cells were no longer in one layer but in two layers,
apparently with one neuronal-like cell type growing on top of
the other cell type with a distinctly different cell morphology
(Fig. 1c). After 10 days in differentiation medium, a ﬁne network
of neurites and dense, rounded cell bodies were formed on top of
the other cell type (Fig. 1d).
4.2. mRNA and protein levels of cell type-speciﬁc biomarkers in
differentiated C17.2 cells
The mRNA levels of the neural progenitor cell marker nestin
(Fig. 2a) were attenuated after all exposure scenarios (treatments
2–9 in Table 1), as compared to control levels, (treatment 1 in Ta-
ble 1), indicating maturation and differentiation of the C17.2 neu-
ral stem cells. The difference in nestin expression between the
differentiation scenarios was however not signiﬁcant. The mRNA
levels of the neuronal biomarker, bIII-tubulin (Fig. 2b) were the
lowest after 3 days in culture with complete DMEM (treatment 1
in Table 1), which is in accordance with the neural progenitor cell
state. However, when cells were cultured in DMEM:F12 medium
with N2 supplements, NGF and BDNF (treatment 7–9 in Table 1),
there was a signiﬁcant increase in bIII-tubulin mRNA expression
as compared to in the control situation (treatment 1 in Table 1).
No signiﬁcant difference in the bIII-tubulin expression was ob-
served between treatments in conditioned DMEM:F12 medium
with N2 supplements but no extra addition of neurotrophic factors
(treatment 7 in Table 1), conditioned DMEM:F12 medium with N2supplements and extra addition of neurotrophic factors (treatment
8 in Table 1) or change of DMEM:F12 medium with N2 supple-
ments and neurotrophic factors every 3rd to 4th day (treatment
9 in Table 1). The bIII-tubulin expression was also increased, how-
ever not statistically signiﬁcant, in cells differentiated in DMEM
with 5% HS and neurotrophic factors (treatment 4–6 in Table 1).
The mRNA level of GFAP was very low in the progenitor cells
(Fig. 2c) and the GFAP mRNA expression differed between the
treatments (2–9 in Table 1). The highest mRNA levels were found
in cultures treated with DMEM:F12 mediumwith N2 supplements,
NGF and BDNF, which was changed to fresh medium after 4 days.
Taken together, the nestin mRNA level was attenuated when the
progenitor cells differentiated to cells expressing bIII-tubulin or
GFAP, conﬁrming a mixed culture of neurons and astrocytes
respectively.
Concomitantly with the mRNA expression, the protein levels of
nestin, bIII-tubulin and GFAP were determined by western blot
analyses after culturing the cells for 7 days in DMEM:F12 medium
with N2 supplements, NGF and BDNF and with the differentiation
medium changed to fresh medium after 4 days. The total nestin
protein level was signiﬁcantly down-regulated as compared to
the progenitor cells whereas both bIII-tubulin and GFAP protein
levels were up-regulated as compared to the progenitor cells
(Fig. 3), further indicating that a mixed culture of neurons and
astrocytes was obtained.
5. Discussion
Previous reports show that cell lines are not sufﬁcient and com-
plex enough to be used as a single model for estimation of systemic
toxicity of a broad spectrum of chemicals (Anon, 2006; Ekwall,
1999; Forsby et al., 2009; Gustafsson et al., 2010). In line with this
conclusion other more complex cell models have to be developed.
Mixed cultures, comprising different cell types, may provide this
tool. Here we describe an optimised cell culture protocol for neuro-
nal and glia cell maturation of an immortalised neural stem cell
line originating from mouse cerebellum. The C17.2 cells have pre-
viously been used in investigations of therapeutic transplantation
in the treatment of neurodegenerative disorders in mouse models
Fig. 2. Nestin, bIII-tubulin and GFAP mRNA levels in differentiated C17.2 cells. Cells
were lysed and mRNA was isolated after 7 days of differentiation (bars 2–9) or after
3 days in complete DMEM as control (bar 1). The bar numbering refers to the
culture conditions indicated in Table 1. Expression of nestin, bIII-tubulin and GFAP
were analysed by RT-PCR. GAPDH was used as a reference gene. Data (ratio of
arbitrary units, AU) represent means ± SEM of four independent experiments, each
performed in duplicates,and were analysed by one-way ANOVA, followed by
Tukey’s multiple comparison test,  p < 0.01 and p < 0.05 as compared with mRNA
levels in control cells.
Fig. 3. Nestin, bIII-tubulin and GFAP protein levels in differentiated C17.2 cells.
Cells were lysed and the protein content was analysed after 7 days of treatment in
DMEM:F12 with N2 supplement, NGF and BDNF. Cells cultured in complete DMEM
served as a control (C) (a) Quantitative analyses of protein expression in relation to
b-actin expression, (b) one representative western blot image visualising levels of
nestin, bIII-tubulin, GFAP and b-actin. Bars display mean ± SEM of n = 3 (nestin) or
n = 4 (bIII-tubulin and GFAP) independent experiments, performed in duplicates.
Results were analysed by Student’s t-test, p < 0.05.
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ject was to differentiate the cells into a mixed culture of neurons
and astrocytes in a controlled manner. Previous studies have
shown that the C17.2 cells secrete NGF and BDNF, but also glial
cell-line derived neurotrophic factor, stimulating autocrine induc-
tion of differentiation (Lu et al., 2003; Niles et al., 2004). Indeed,
just leaving the cells in complete DMEM for 8 days decreased the
nestin expression and increased the expression of bIII-tubulinand GFAP. However, no medium change during the whole differen-
tiation period (with or without addition of extra neurotrophic
factors) is a less controlled culture condition which generated a
fraction of detached, presumably dead cells (not shown). It also
seemed that the GFAP expression was stimulated, without
attenuating bIII-tubulin expression, if the media were changed
with 3–4 days of intervals (Fig. 2c). Increased GFAP expression
could, however, be a sign of induction of reactive astrocytes, but
since this step of differentiation was not evident in the morpho-
logic evaluation (Fig. 1) it seems unlikely.
The serum-free differentiation medium, i.e. DMEM:F12 medium
with N2 supplements, NGF and BDNF, generated cultures with two
distinct morphological phenotypes assumed to be neurons and
astrocytes (Fig. 1). Along with the visual indication of two different
phenotypes, a signiﬁcant increase in the bIII-tubulin and GFAP
expression was evident at the mRNA as well as the protein levels
(Figs. 2 and 3). The decrease in nestin expression further supports
the conclusion that the neural progenitor cells differentiated and
that a mixed cell culture of neurons and astrocytes was obtained
after 7 days in the serum-free DMEM:F12 mediumwith N2 supple-
ments, NGF and BDNF.
Taken together, the mixed culture of neurons and astrocytes ob-
tained in serum-free differentiation medium without any artiﬁcial
extracellular matrix, together with the fact the C17.2 cells are easy
to handle, makes the cell line a good candidate as an alternative to
primary brain cell cultures for toxicological evaluation of
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